Intervention

Mycophenolate Mofetil

ClinicalTrials.gov intervention label

Clinical trials13
Recruiting1
Common conditions25
Lead sponsors shown12

Clinical trials

13 shown
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesNCT04959175 · 2021-09-23
RECRUITING
Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory CardiomyopathyNCT05570409 · 2023-03-28
TERMINATED
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)NCT05049863 · 2023-02-27
TERMINATED
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side EffectsNCT03315052 · 2019-01-01
WITHDRAWN
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreNCT03386539 · 2018-01-29
COMPLETED
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETED
Scleroderma Treatment With Autologous Transplant (STAT) StudyNCT01413100 · 2011-09-15
COMPLETED
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsNCT01304836 · 2011-01-22
COMPLETED
LEA29Y (Belatacept) Emory Edmonton ProtocolNCT00468403 · 2008-10-01
COMPLETED
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney TransplantNCT00790439 · 2008-07-01
WITHDRAWN
Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney TransplantationNCT03582878 · 2004-01-01
COMPLETED
Rheumatoid Arthritis:Tolerance Induction by Mixed ChimerismNCT00282412 · 2002-09-01
TERMINATED
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas RecipientsNCT00533442 · 2000-09-01
COMPLETED

Common conditions

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Acute Biphenotypic Leukemia1Acute Cellular Graft Rejection1Acute Leukemia1Acute Lymphoblastic Leukemia1Acute Lymphoblastic Leukemia in Remission1Acute Myeloid Leukemia1Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1Cardiac Allograft Vasculopathy1Chemotherapy-Related Leukemia1Chronic Kidney Diseases1Chronic Lymphocytic Leukemia1Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Chronic Myelomonocytic Leukemia1Diabetes Mellitus, Type 11Diabetes Mellitus, Type I1Heart Transplant Failure and Rejection1Heart Transplant Infection1Hematologic Neoplasms1Hodgkin Lymphoma1Immunosuppression1Inflammatory Cardiomyopathy1Kidney Transplantation1Langerhans Cell Histiocytosis1Liver Transplant Rejection1

Trial status mix

COMPLETED7
TERMINATED3
WITHDRAWN2
RECRUITING1

Phase mix

PHASE27
PHASE13
PHASE43
PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.